Targeting K


Journal

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
ISSN: 1421-9778
Titre abrégé: Cell Physiol Biochem
Pays: Germany
ID NLM: 9113221

Informations de publication

Date de publication:
28 May 2021
Historique:
accepted: 26 04 2021
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 2 9 2021
Statut: ppublish

Résumé

The K

Identifiants

pubmed: 34043300
doi: 10.33594/000000374
doi:

Substances chimiques

Acetamides 0
Antineoplastic Agents 0
Antisickling Agents 0
KCNN1 protein, human 0
Potassium Channel Blockers 0
Small-Conductance Calcium-Activated Potassium Channels 0
Trityl Compounds 0
Calcium SY7Q814VUP
senicapoc TS6G201A6Q

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-144

Subventions

Organisme : Deutsche Forschungsgemeinschaft (DFG)
ID : GRK 2515/1
Pays : Germany

Informations de copyright

© Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Luca Matteo Todesca (LM)

Institut für Physiologie II, Westfälische Wilhelms-Universität Münster, Münster, Germany.

Sarah Maskri (S)

Institute for Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.

Kathrin Brömmel (K)

Medizinische Klinik A, Westfälische Wilhelms-Universität Münster, Münster, Germany.

Insa Thale (I)

Institute for Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.

Bernhard Wünsch (B)

Institute for Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.

Oliver Koch (O)

Institute for Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.

Albrecht Schwab (A)

Institut für Physiologie II, Westfälische Wilhelms-Universität Münster, Münster, Germany, aschwab@uni-muenster.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH